Does combined treatment with novel anti-depressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

Polish Journal of Pharmacology

Volumn 53, Issue 6, 2001, Pages 577-585

  Filip, Malgorzata ^a   Papla, Iwona ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Cocaine; Discriminative stimulus effects; Milnacipram; Pramipexole; Rats; Reboxetine; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; COCAINE; DOPAMINE; DOPAMINE 3 RECEPTOR STIMULATING AGENT; MILNACIPRAM; MONOAMINE DERIVATIVE; MORPHINE; NEUROTRANSMITTER; NORADRENALIN; PRAMIPEXOLE; REBOXETINE; SEROTONIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VENLAFAXINE; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG MECHANISM; MALE; MODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TRAINING; WITHDRAWAL SYNDROME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZOTHIAZOLES; COCAINE; CYCLOHEXANOLS; CYCLOPROPANES; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INFUSIONS, PARENTERAL; MALE; MORPHOLINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SEROTONIN UPTAKE INHIBITORS; THIAZOLES;

EID: 0035689848     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: Intraindividual variability and plasma concentration correlations
2. Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe
3. 3 dopamine antagonist PNU-99194A in rats: Comparison with psychomotor stimulants
4. Analysis of the effects of diverse antidepressants on the discriminative stimulus effects of cocaine
5. 1B receptor agonists
6. Fluoxetine reduces intravenous cocaine self-administration in rats
7. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan
8. 3 dopamine receptor-deficient mice
9. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxepride, but not PNU-99194A
10. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat
11. 3 antagonist DS 121 potentiates the effects of cocaine on locomotion and reduces tolerance in cocaine tolerant rats
12. 1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats
13. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats
14. 3 receptor-selective ligands in rats trained to discriminate cocaine from saline
15. Dopamine receptors: Molecular biology, biochemistry and behavioral aspects
16. The discriminative stimulus effects of cocaine in pigeons
17. 3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics
18. 3 dopamine receptor agonists in rats
19. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine and apomorphine in the rat
20. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
21. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine
22. 3 preferring dopamine agonist pramipexole on sleep and walking, locomotor activity and striatal dopamine release in rats
23. 3 receptor agents as potential new medications of drug addiction
24. A simplified method of evaluation dose-effect experiments
25. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor
26. Serotonergic inhibition of catecholamine-induced behavioral arousal
27. 1-adrenergic, dopaminergic and serotonergic receptors in rat brain
28. 1-adrenergic, dopamine and serotonin systems
29. 3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims
30. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors. I. Receptorial, electrophysiological and neurochemical profile compared with GR 218,231 and L741,626
31. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents
32. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethylaminocarbonyl-2-amino-methylcyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug
33. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system
34. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative
35. New antidepressants and the cytochrome P450 system: Focus on venlafaxine, nefazodone, and mirtazepine
36. 3 receptor agonist
37. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes
38. Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76
39. Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioral and biochemical studies
40. The pharmacological profile of venlafaxine, a new antidepressant, given acutely
41. Pharmacological profile of milnacipram, a new antidepressant, given acutely
42. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely
43. Relationship between the discriminative stimulus properties and subjective effects of drugs
44. 3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys
45. Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys
46. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys
47. Psychopharmacology of milnacipram, 1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant
48. Do antidepressants affect motivation in conditioned place preference?
49. Effects of monoamine reuptake inhibitors on cocaine self-administration in rats
50. 3 agonist PD 128907 on brain dopamine sythesis in rat
51. Prozac (Fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
52. Pharmacological selectivity of reboxetine, a selective noradrenaline reuptake inhibitor (NARI)
53. Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys
54. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen
55. 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: Synthesis and antidepressant activity